AZO vs FDMT · P/E 21, rev $18.94B vs rev $37.0K
AutoZone Inc (AZO) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
AZO currently screens at market cap $50.08B and trailing P/E 21.0. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the AZO and FDMT stock pages for the full models.
Not investment advice.